Literature DB >> 10482260

A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions.

H Lerche1, C Biervert, A K Alekov, L Schleithoff, M Lindner, W Klinger, F Bretschneider, N Mitrovic, K Jurkat-Rott, H Bode, F Lehmann-Horn, O K Steinlein.   

Abstract

Benign familial neonatal convulsions (BFNC) is a rare dominantly inherited epileptic syndrome characterized by frequent brief seizures within the first days of life. The disease is caused by mutations in one of two recently identified voltage-gated potassium channel genes, KCNQ2 or KCNQ3. Here, we describe a four-generation BFNC family carrying a novel mutation within the distal, unconserved C-terminal domain of KCNQ2, a 1-bp deletion, 2513delG, in codon 838 predicting substitution of the last seven and extension by another 56 amino acids. Three family members suffering from febrile but not from neonatal convulsions do not carry the mutation, confirming that febrile convulsions and BFNC are of different pathogenesis. Functional expression of the mutant channel in Xenopus oocytes revealed a reduction of the potassium current to 5% of the wild-type current, but the voltage sensitivity and kinetics were not significantly changed. To find out whether the loss of the last seven amino acids or the C-terminal extension because of 2513delG causes the phenotype, a second, artificial mutation was constructed yielding a stop codon at position 838. This truncation increased the potassium current by twofold compared with the wild type, indicating that the pathological extension produces the phenotype, and suggesting an important role of the distal, unconserved C-terminal domain of this channel. Our results indicate that BFNC is caused by a decreased potassium current impairing repolarization of the neuronal cell membrane, which results in hyperexcitability of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482260     DOI: 10.1002/1531-8249(199909)46:3<305::aid-ana5>3.0.co;2-5

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

1.  Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors.

Authors:  A A Selyanko; J K Hadley; I C Wood; F C Abogadie; T J Jentsch; D A Brown
Journal:  J Physiol       Date:  2000-02-01       Impact factor: 5.182

2.  Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.

Authors:  A A Selyanko; J K Hadley; D A Brown
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

3.  A novel degradation signal derived from distal C-terminal frameshift mutations of KCNQ2 protein which cause neonatal epilepsy.

Authors:  Jun Su; Xu Cao; KeWei Wang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 4.  Nanotechnology for neuronal ion channels.

Authors:  F Lehmann-Horn; K Jurkat-Rott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

5.  The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine.

Authors:  Ruhma Syeda; Jose S Santos; Mauricio Montal
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

6.  Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation.

Authors:  Ainhoa Etxeberria; Irene Santana-Castro; M Paz Regalado; Paloma Aivar; Alvaro Villarroel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

7.  Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in the KCNQ2 and KCNQ3 C-terminal domains.

Authors:  Hee Jung Chung; Yuh Nung Jan; Lily Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

8.  C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.

Authors:  Snezana Maljevic; Christian Lerche; Guiscard Seebohm; Alexi K Alekov; Andreas E Busch; Holger Lerche
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

Review 9.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

10.  Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels.

Authors:  Hua Wen; Irwin B Levitan
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.